Antimicrobial Agents and Chemotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.2 | Q2 | 71.6% | 1.473 | Q1 | 91.7% |
| 2024 | 4.5 | Q1 | 82.2% | 1.431 | Q1 | 91.5% |
| 2023 | 4.1 | Q1 | 78.7% | 1.357 | Q1 | 91.4% |
| 2022 | 4.9 | Q1 | 82.5% | 1.415 | Q1 | 92.4% |
| 2021 | 5.9 | Q1 | 85.0% | 1.546 | Q1 | 93.4% |
| 2020 | — | — | 2.070 | Q1 | 95.8% | |
| 2019 | — | — | 2.135 | Q1 | 96.1% | |
| 2018 | — | — | 2.096 | Q1 | 95.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0066-4804
ISSN
1098-6596
country
UScoverage
1963-1970, 1972-2026